BOSTON – Efficacy of the the respiratory syncytial virus (RSV) vaccine held strong for at least two RSV seasons in older adults, according to the AReSVi-006 study.
The RSV perfusion… Read More
Antiviral Drugs Market Growth & Trends
The global antiviral drugs market size is expected to reach USD 60.0 billion by 2028, according to a new report by Grand View Research, Inc… Read More
Antiviral Drugs Market Growth & Trends
The global antiviral drugs market size is expected to reach USD 60.0 billion by 2028, according to a new report by Grand View Research, Inc… Read More
On June 20, 2023, Cidara Therapeutics will be in the spotlight as a biotechnology company that is dedicated to developing long-acting therapeutics that can improve the standard of care for p… Read More
medicamentoAR NEWS NOTÍCIAS 24 horas
🔵Para as últimas manchetes, siga nosso canal do Google Notícias on-line ou pelo aplicativo. 📰 aquiA Cidara Th… Read More
Cidara Therapeutics and Melinta Therapeutics recently announced that Rezzayo (rezafungin for injection) has been approved by the US Food and Drug Administration (FDA). The antifungal drug wa… Read More
The Food and Drug Administration has approved injectable rezafungin for treating candidemia and invasive candidiasis in adults for people with limited or no other options.Weekly injectable R… Read More
DelveInsight’s, “Aspergillosis Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Aspergillosis pipeline lan… Read More
The Candidemia Market is anticipated to show positive growth, mainly attributed to the increasing incident cases and also, the launch of upcoming therapies during the forecast period. Moreo… Read More
DelveInsight’s, Influenza Pipeline Insight 2022 report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipe… Read More
Stocks under $1 can bring big gains. But, you have to find the right ones. And the world of stocks can seem daunting. Especially when some cost hundreds or even thousands of dollars per shar… Read More
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced Read More
SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced… Read More
Last week we had mentioned how the US dollar upon the MACDs would be seeing the negative red line taking control, this just happened going into the Tuesday morning… Read More
Multiple brokerage websites this morning were going through technical issues and was having issues on Sunday in trying to get updated stock future's going into Monday morning 1… Read More
Stock futures are moving up since after the close on Friday (10/2/20) with the: DOW up by .51 percent the S & P 500 up by .51 percent and the NASDAQ is up by … Read More
Long-lasting treatments for invasive fungal disease are becoming ever more necessary but there are many challenges to overcome in drug development. Natalie Healey talks to Cidara Therapeutic… Read More
as CH3COOH salt CD 101Several structural representations aboveBiafungin™; CD 101 IV; CD 101 Topical; CD101; SP 3025, Biafungin acetate, Echinocandin BUNII-G01… Read More